Tag
#alzheimer's disease
1 study
Weight LossMay 20, 2026
RCT·The Lancet
Popular GLP-1 Drug Fails to Slow Alzheimer's Disease Progression
Despite early promise, a large clinical trial reveals that the popular GLP-1 drug semaglutide does not slow down cognitive decline in early-stage Alzheimer's disease.
Read Analysis